We thank 45+ health systems, representing 1,200+ hospitals across the US, for joining Civica Rx to help ensure quality medicines are accessible and affordable to everyone. These include:
Civica Rx and Hikma Pharmaceuticals, the multinational generic pharmaceutical company, today announced imminent shipments of Heparin Sodium Injection, USP, and seven other essential injectable medicines, with additional products to follow in the near term in the US through its affiliate, Hikma Pharmaceuticals USA Inc. Today's announcement comes as industry experts work to avoid an...
Modern Healthcare names Martin VanTrieste, President and CEO of Civica Rx, as one of The 100 Most Influential People in Healthcare. “This recognition is a reflection of everything the Civica team has accomplished, and the great things we will do as a team in the future,” said VanTrieste. “I am honored to receive this recognition...
Important steps taken to address generic drug shortages - a problem that has become a national crisis that impacts the U.S. medical community daily. The last week of October 2019 proved to be an active one on the subject of generic drug shortages and the urgent need to address them. Civica applauds the focus...
Over the past two decades, shortages of generic, injectable drugs critical to the lifesaving work of hospitals in the United States have become commonplace. These drug shortages are so ubiquitous that hospitals and health care systems now maintain permanent drug shortage response teams that seek alternatives to unavailable drugs.
As a result, time that hospital pharmacists, technicians, nurses and others would prefer to spend caring for patients is spent ensuring that the patients who most need short-supply drugs get whatever supply is available.
Civica was created to reduce and prevent drug shortages and the price spikes that can accompany them. Its mission is to make quality generic medicines accessible and affordable to everyone.